Health Care & Life Sciences » Biotechnology | Anthera Pharmaceuticals Inc.

Anthera Pharmaceuticals Inc.

Anthera Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.7
Market Cap
$1.64 M
Shares Outstanding
26.18 M
Public Float
26.12 M

Profile

Address
25801 Industrial Boulevard
Hayward California 94545
United States
Employees -
Website http://www.anthera.com
Updated 07/08/2019
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines to treat serious and life threatening diseases. It offers Sollpura and blisibimod to treat diseases such as exocrine pancreatic insufficiency and Immunoglobulin A nephropathy. The company was founded by Paul F.

Financials

View All
Created with Highcharts 5.0.14Anthera Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.30 86130 86129 60429 60435 22035 22055 52355 52326 87426 87420132014201520162017010k20k30k40k50k60k
Created with Highcharts 5.0.14Anthera Pharmaceuticals Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.00003 1853 185145145002013201420152016201701k2k3k4k

Paul F. Truex
Executive Chairman
John Craig Thompson
President, CEO & Executive Director